Stephen Beard Sells 2,529 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 2,529 shares of the business’s stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $130.78, for a total transaction of $330,742.62. Following the transaction, the chief executive officer owned 424,033 shares of the company’s stock, valued at approximately $55,455,035.74. The trade was a 0.59% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 2.8%

Shares of CVSA stock opened at $128.23 on Friday. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. The stock’s fifty day moving average price is $120.70. The firm has a market capitalization of $4.36 billion, a P/E ratio of 19.97, a P/E/G ratio of 1.07 and a beta of 0.62. Adtalem Global Education Inc. has a 12 month low of $86.97 and a 12 month high of $156.26.

Adtalem Global Education (NYSE:CVSA) last issued its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. The firm had revenue of $487.03 million during the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities analysts forecast that Adtalem Global Education Inc. will post 8.04 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CVSA shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Wall Street Zen upgraded shares of Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Truist Financial upped their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Finally, Barrington Research restated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research note on Monday, June 8th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Adtalem Global Education currently has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.